Could a new staging system better predict esophageal cancer outcomes?
NCT ID NCT07488624
First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times
Summary
This study analyzed data from 414 esophageal cancer patients who received chemoimmunotherapy before surgery. Researchers developed a new 'bio-anatomical' staging system that combines tumor characteristics and immune response to better predict survival and guide post-surgery treatment decisions. The goal is to improve upon traditional staging methods for personalized care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate tool for doctors to predict survival and choose the best follow-up treatment for esophageal cancer patients after chemoimmunotherapy and surgery.
- What could go wrong
- This is a retrospective observational study, not a clinical trial testing a new treatment. The model needs further validation in prospective studies before it can be used in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mianzhu People's Hospital (West China Mianzhu Hospital, Sichuan University)
Mianzhu, Sichuan, 618200, China
-
Suining Central Hospital
Suining, Sichuan, 629000, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a new drug rally the immune system against Hard-to-Treat cancers?
- AI biomarker may reveal who responds to esophageal cancer immunotherapy
- Can a single Protein's mutations predict esophageal cancer outcomes?
- A sponge you swallow could detect esophageal cancer before it spreads